Generation Bio (GBIO) Liabilities and Shareholders Equity (2021 - 2025)
Historic Liabilities and Shareholders Equity for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $121.9 million.
- Generation Bio's Liabilities and Shareholders Equity fell 5100.33% to $121.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $733.9 million, marking a year-over-year decrease of 3752.6%. This contributed to the annual value of $231.2 million for FY2024, which is 3830.77% down from last year.
- Per Generation Bio's latest filing, its Liabilities and Shareholders Equity stood at $121.9 million for Q3 2025, which was down 5100.33% from $179.4 million recorded in Q2 2025.
- Generation Bio's 5-year Liabilities and Shareholders Equity high stood at $514.1 million for Q1 2021, and its period low was $121.9 million during Q3 2025.
- Over the past 5 years, Generation Bio's median Liabilities and Shareholders Equity value was $381.5 million (recorded in 2023), while the average stood at $353.4 million.
- Per our database at Business Quant, Generation Bio's Liabilities and Shareholders Equity tumbled by 40.03% in 2023 and then crashed by 5100.33% in 2025.
- Generation Bio's Liabilities and Shareholders Equity (Quarter) stood at $476.8 million in 2021, then fell by 21.08% to $376.3 million in 2022, then dropped by 0.4% to $374.8 million in 2023, then plummeted by 38.31% to $231.2 million in 2024, then tumbled by 47.28% to $121.9 million in 2025.
- Its Liabilities and Shareholders Equity was $121.9 million in Q3 2025, compared to $179.4 million in Q2 2025 and $201.3 million in Q1 2025.